药物对比
Fremanezumab vs Lasmiditan
Compare Ajovy (fremanezumab, CGRP mAb preventive) and Reyvow (lasmiditan, 5-HT1F acute treatment) for migraine: uses, efficacy, safety.
此页面暂无可用的对比维度。
临床背景
This comparison is triggered when evaluating preventive versus acute pharmacologic options for adults with migraine.
结论
Fremanezumab and Lasmiditan target distinct phases of migraine care and are not directly interchangeable.
全部药物对比